Arrowhead Research reported $195K in Ordinary Share Capital for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Agios Pharmaceuticals AGIO:US $ 0.07M 0M
Alnylam Pharmaceuticals ALNY:US $ 1.16M 0M
Anika Therapeutics ANIK:US $ 0.14M 0M
Arrowhead Research ARWR:US $ 195K 250
Bluebird Bio BLUE:US $ 0.66M 0M
Cerulean Pharma CERU:US $ 0M 0M
Dicerna Pharmaceuticals DRNA:US $ 0.01M 0M
Heron Therapeutics HRTX:US $ 0.91M 0M
Intercept Pharmaceuticals ICPT:US $ 0.03M 0M
Mirati Therapeutics MRTX:US $ 0.04M 0M
Moderna Inc MRNA:US 40K 1000
Nektar Therapeutics NKTR:US $ 0.02M 0M
Opko Health OPK:US $ 6.71M 0M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
Spectrum Pharmaceuticals SPPI:US $ 0.15M 0.03M
Tg Therapeutics TGTX:US $ 0.13M 0M
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0.01M
Vertex Pharmaceuticals VRTX:US $ 2.6M 0M
YTE INCY:US $ 0.22M 0M